Metformin Hydrochloride Tillomed (Metformin Hydrochloride)

Metformin Hydrochloride is indicated for conditions related to impaired glucose regulation and insulin resistance.

• Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels.
• Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes when combined with diet and exercise interventions.
• Polycystic ovary syndrome: reduces insulin resistance, which may improve menstrual regularity and ovulation rates in affected women.

• Metformin Hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which decreases hepatic gluconeogenesis. The resulting reduction in hepatic glucose output, together with increased peripheral glucose uptake and enhanced insulin receptor tyrosine kinase activity, improves insulin sensitivity in muscle and adipose tissue. It does not stimulate insulin secretion, thereby lowering the risk of hypoglycemia when used alone.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Gastrointestinal upset: nausea, abdominal discomfort, and loss of appetite.
• Diarrhea: frequent loose stools, especially during treatment initiation.
• Metallic taste: transient alteration of taste perception.
• Weight loss: modest reduction in body weight.
• Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects

• Lactic acidosis: a rare but life‑threatening accumulation of lactate.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: marked elevation of liver enzymes or hepatitis.

When prescribing Metformin Hydrochloride, clinicians should consider several safety measures.

• Renal function assessment: evaluate creatinine clearance before initiation and periodically thereafter.
• Hepatic function monitoring: avoid use in patients with significant liver disease.
• Risk of lactic acidosis: contraindicated in conditions predisposing to hypoxia or severe infection.
• Elderly dosing: start at lower doses and titrate cautiously.
• Concomitant medication review: assess for drugs that may affect renal clearance.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metformin Hydrochloride can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

• Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
• Alcohol excess: enhances the potential for lactic acidosis.
• Cimetidine: can increase metformin plasma concentrations.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycemia symptoms.
• ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment.
• NSAIDs: may reduce renal clearance of metformin.
• Corticosteroids: can raise blood glucose, necessitating closer monitoring.
• Thyroid hormones: may alter glucose metabolism, requiring dose reassessment.